<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-BGD-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Bangladesh (le): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Bangladesh: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-44001" role="4" type="40">
   <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
  </participating-org>
  <participating-org ref="US-EIN-91-1157127" role="4">
   <narrative xml:lang="EN">PATH</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Bangladesh</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="BD" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="BD" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Dhaka</narrative>
   </name>
   <administrative code="BD" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>26.68333 85.16667</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1394099</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1878626</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1099279</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">99724</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="BGDPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">12000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">84000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-IBRD2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-STI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">174245</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">8600</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">265764</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">649490</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">123200</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-PATH2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">69163</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-STI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">24715</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">622631</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1038917</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-PATH2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">304764</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">23426</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">305640</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">465450</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BGDPEF-TCA-PATH2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">99724</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000959">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">12000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000960">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">84000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">123200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001135">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004608">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">45400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006613">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">77763</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000421">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-17"></transaction-date>
   <value currency="USD" value-date="2022-01-17">50567</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001043">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">80875</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001210">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-100000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001340">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">4883</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">188486</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-188486</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000602">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-03"></transaction-date>
   <value currency="USD" value-date="2020-03-03">141218</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">7607</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-513</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">15715</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-5426</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">5426</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-1200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">1200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000961">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">265763</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">270011</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">352620</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004024">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-26"></transaction-date>
   <value currency="USD" value-date="2021-08-26">305640</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000962">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">649490</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">649490</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">389427</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004708">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">465450</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-bangladesh-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Bangladesh 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-bangladesh-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Bangladesh 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-bangladesh-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Bangladesh 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-bangladesh-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Bangladesh 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-bangladesh-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Bangladesh 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-bangladesh-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Bangladesh 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-bangladesh-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Bangladesh 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-bangladesh-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Bangladesh 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-07-27"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-BGD" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rota vaccine introduced</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for preparation, implementation and evaluation of new vaccine introduction (Rota, HPV, JE, typhoid and others)">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">Bangladesh has not yet decided on Rota introduction. A technical committee was formed by the government to review rota application and disease burden. The committee has not yet submitted final report to Ministry due to COVID pandemic</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report on lesson learned from implementation of e-tracker</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for planning, monitoring and evaluation of immunization e-tracker through DHIS2 in selected districts and city corporations">
      <location ref="BD"></location>
     </target>
     <actual value="On Track">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">Immunization Individual Tracking System (EPI e-tracker) initiative is being implemented in Moulvibazar District and Zone-5 under Dhaka South City Corporation (DSCC) since March 2019. James P. Grant School of Public Health (JPGSPH) department under BRAC University has been hired through institutional Partnership Cooperation Agreement (PCA) to conduct the evaluation with the objectives:
?	To understand the delivery mechanism and fidelity of e-tracking intervention in Moulvibazar and Dhaka South City Corporation (Zone-5) 
?	To explore the acceptance and understand the experience of the beneficiaries of e-tracking intervention 
?	To assess the bottlenecks and facilitators for implementers in implementing e-Tracking intervention 
?	To document lessons learned, best practices related to e-tracking intervention. 
Evaluation team has completed quantitative data collection of E-tracker and the qualitative data collection is in progress which will be completed by 15 June 2021, and the final evaluation report will be prepared and disseminated by July 2021. However due to current Covid19 situation, it might be further delayed. (Detail is attached as ?Brief report on e-tracker assessment?).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluation&#xA0;of intervention conducted at least in&#xA0;1 CC</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to map unimmunized and left out children,&#xA0; hard to reach, indigenous and urban slum thorugh&#xA0; micro planning&#xA0; and use of innovative stratgies to ensure high immunization coverage and equity,">
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">Bangladesh introduced electronic registration of target children for immunization in 2 CC. Evaluation of intervention was conducted to review whether this could be further expanded. report on evaluation attached.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to map unimmunized and left out children,&#xA0; hard to reach, indigenous and urban slum thorugh&#xA0; micro planning&#xA0; and use of innovative stratgies to ensure high immunization coverage and equity,">
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">Bangladesh introduced electronic registration of target children for immunization in 2 CC. Evaluation of intervention was conducted to review whether this could be further expanded. report on evaluation attached.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluation of full immunization initiative evaluetd</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement innovative approaches for community mobilization and build ownership for full immunization innitiative &amp; appreciating inquiry,&#xA0;exposure visit and evaluation of full immunization">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">Although the evaluation was not formally conducted, the CES 2019 projects District like Joypurhat made significant progress in terms of full immunization initiative ( From CES 2016 (80.4%) to CES 2019 (94.6%). Since this evaluation is linked with the full immunization implementation activities by GoB local health authorities, as they were repurposed to COVID-19 response, therefore it could not be conducted.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement innovative approaches for community mobilization and build ownership for full immunization innitiative &amp; appreciating inquiry,&#xA0;exposure visit and evaluation of full immunization">
      <location ref="BD"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">In the EPI coverage evaluation survey that was conducted in 2019, the result showed that Joypurhat District full vaccination coverage by 12 months of age children was 94.6% which was the 2nd highest among Districts in the country. Joypurhat District was the first District that started the implementation of the full immunization initiative in November 2018 and ended all the proposed activities before conducting the field survey of routine CES 2019. Although the process of the full immunization initiative was not possible to evaluate because of the COVID</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement innovative approaches for community mobilization and build ownership for full immunization innitiative &amp; appreciating inquiry,&#xA0;exposure visit and evaluation of full immunization">
      <location ref="BD"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">In the EPI coverage evaluation survey that was conducted in 2019, the result showed that Joypurhat District full vaccination coverage by 12 months of age children was 94.6% which was the 2nd highest among Districts in the country. Joypurhat District was the first District that started the implementation of the full immunization initiative in November 2018 and ended all the proposed activities before conducting the field survey of routine CES 2019. Although the process of the full immunization initiative was not possible to evaluate because of the COVID</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 1 district and one CC/municipality declared as fully immunized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement innovative approaches for community mobilization and build ownership for full immunization innitiative &amp; appreciating inquiry,&#xA0;exposure visit and evaluation of full immunization">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">The full immunization initiative has been implementing in the Noagoan Municipality, Noagoan District for community mobilization and to build ownership. The Municipality has been declared in the EPI model in early 2020. Through this initiative Children under 2-year-old have received appropriate doses of vaccines as per the national EPI schedule and drop-out children have tracked for subsequent doses. Advocacy meeting has been organized with participated of local leaders, City Corporation officials, NGOs, journalist and religion leaders. Orientation/Training of health workers and 1st line supervisors: Orientation/Training has been conducted with an assigned task to them to register all children under 2 years after housing to house visit and ensured vaccination. A computerized EPI database has been developed for all registered children and dropout and left out children were assessed. Dissemination meeting has been conducted with the participation of district administration, local government, National EPI, Journalist, and development partners and declared this Municipality as EPI model. 
 The plan has been developed to implement this innovative initiative in Rajshahi City Corporation. The national team has visited Rajshahi City Corporation in March 2020 and met with the Mayor, Rajshahi City Corporation to share the detailed plan of implementation in that City Corporation. Mayor, Rajshahi City Corporation was excited to implement this initiative in his City Corporation. We are hopeful to start implementing soon after the situation gets improved.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">electronic registration of all children completed in 2 CC</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to map unimmunized and left out children,&#xA0; hard to reach, indigenous and urban slum thorugh&#xA0; micro planning&#xA0; and use of innovative stratgies to ensure high immunization coverage and equity,">
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">electronic registration completed in 2 CC. But this could not be expanded to other CC due to COVID. Report attached</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">95% of special outreach sessions held as per micro-plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for sustainable improvement of immunization coverage in urban areas particularly for the poorest and most vulnerable groups">
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">Bangladesh reached 84% children with Fully Vaccination Coverage (FVC) by age of 12 months, but the urban areas are still lagging behind that reached 77% children with FVC. The key challenges are rapid growing, floating population, weak infrastructure, coordination gaps, shortage of vaccinators etc. To address all these challenges, National Urban Immunization Strategy had been developed and approved in 2019. In line with the approved strategy and action plan; large City corporations like Dhaka South City Corporation, Dhaka North City Corporation, Chittagong City corporation and Gazipur City Corporation has developed special EPI outreach sessions plan for mobile population, working mothers and high risk groups to improve accessibility as well as improve immunization coverage in urban areas. As planned, four City Corporations conducted planned special vaccination session including regular planned outreach and fixed sessions. Mobile population, working mothers and the mothers living in urban slums were the main beneficiary of special outreach sessions. 
According to the routine HMIS data, in 2021 from January to May there are total 79,182 EPI session held against 81,223 EPI session planned (97% session held) in four city corporations and municipalities as per the micro plan. This progress was made despite nationwide lockdown due to Covid19 pandemic started from April 2021 to till date.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for sustainable improvement of immunization coverage in urban areas particularly for the poorest and most vulnerable groups">
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">Bangladesh reached 84% children with Fully Vaccination Coverage (FVC) by age of 12 months, but the urban areas are still lagging behind that reached 77% children with FVC. The key challenges are rapid growing, floating population, weak infrastructure, coordination gaps, shortage of vaccinators etc. To address all these challenges, National Urban Immunization Strategy had been developed and approved in 2019. In line with the approved strategy and action plan; large City corporations like Dhaka South City Corporation, Dhaka North City Corporation, Chittagong City corporation and Gazipur City Corporation has developed special EPI outreach sessions plan for mobile population, working mothers and high risk groups to improve accessibility as well as improve immunization coverage in urban areas. As planned, four City Corporations conducted planned special vaccination session including regular planned outreach and fixed sessions. Mobile population, working mothers and the mothers living in urban slums were the main beneficiary of special outreach sessions. 
According to the routine HMIS data, in 2021 from January to May there are total 79,182 EPI session held against 81,223 EPI session planned (97% session held) in four city corporations and municipalities as per the micro plan. This progress was made despite nationwide lockdown due to Covid19 pandemic started from April 2021 to till date.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">at least 10% of missed and left out children identified and reached with vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Accelerated Outreach Efforts to measure the impact of SIA activities on catching-up missed vaccination doses">
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">The postponed Measles-Rubella Campaign 2020 was conducted from 12 December 2020 to 31 January 2021. Following activities implemented to reach the missed children;
?	Documentation of zero dose and one dose of MR vaccine in the tally sheet during campaign session and ensured subsequent due and defaulted doses 
?	The ?organization unit? created in DHIS2 for online microplan will be used for RI annual microplan and real time MR monitoring system will be used for RI monitoring.
?	Identified missed area through RCA will be considered as one of the priorities to improve RI 
MR campaign 2020, strengthened routine immunization as the campaign helped to identify and listing down the children who missed any dose of routine immunization due to COVID-19 pandemic situation. During COVID-19 pandemic situation, the RI coverage dropped sharply in the month of April and May 2020, Penta3 and MR1 antigen coverage were only 48% which was continued to decline till June 2020. However, with the implementation of revised guideline and intensive regular monitoring of RI coverage, the coverage improved but even though significant number of children were missed for all antigen. 
From the RI report 2020, an estimated 115,260 children were missed BCG vaccination and 159,245 children missed Penta 1 vaccination against the yearly target. With the adoption of RI strengthening strategy during campaign through listing of missed children for routine vaccine in the tally sheet, a total 119,913 children were listed who missed any dose before campaign. 75% children missed Penta 1 and 99% children missed BCG vaccination during that period.
After completion of MR campaign session, health worker and vaccinator started to vaccinate missed children as per listings and followed-up for subsequent doses to complete full vaccination for all children. All districts and city corporations were advised to complete the vaccination of all missed children by 30 May 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Urban Immunization Costed action plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for sustainable improvement of immunization coverage in urban areas particularly for the poorest and most vulnerable groups">
      <location ref="BD"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">The implementation framework based on the approved National Urban Immunization Strategy 2019 (NIUS2019) has been drafted, to include the activities required to achieve the goal and seven specific objectives set in the NIUS 2019. This will also serve as a guideline to draw specific plans for each and every urban area of the country. Four consultative meetings with different stakeholders at sub-national level has been conducted through ?online Zoom? in May 2021 and the final national level workshop is pending. The Ministry of Health planned to conduct face to face workshop but due to Covid19 situation it has been postponed. The recruitment of consultant for costing the action plan is in process. However, due to current Covid19 situation, it might be further delayed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MR SIA conducted with &gt;95% coverage</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for strengthening routine immunization, implementation of HSS activities and implementation of a high quality MR SIA, with a focus on social mobilization and real time monitoring">
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">The postponed Measles-Rubella Campaign (originally planned for 2020) was conducted from 12 December 2020 to 31 January 2021 with the revised strategies and followed the 3 basic infection prevention principles to mitigate the risk of COVID-19 infection. The 6 weeks rolling campaign was conducted through community fixed and outreach session. UNICEF supported EPI-DGHS to introduce six technology-based innovations in this Measles-Rubella vaccination campaign using DHIS2 platform to ensure quality of the campaign and an equitable high coverage through real time monitoring at national and sub-national levels. The campaign targeted 35 million children aged 9 months to 9 years old and vaccinated 36.5 million children (104%) with one dose MR vaccine under safe conditions, without undue harm to health workers and the community. The detail report is attached as ?Narrative Report MR campaign 2020?.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">at least 50 % RI imporvemnt activities through MR SIA implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Accelerated Outreach Efforts to measure the impact of SIA activities on catching-up missed vaccination doses">
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">The postponed nationwide Measles-Rubella Campaign 2020 held from 12 December 2020 to 31 January 2021 targeting children 9 months to 9 years old. Through the MR campaign following activities implementation to strengthen routine immunization:
1.	Vaccinator training of campaign helps strengthening RI like cold chain management, use of VVM, injection safety, AEFI management, safe waste disposal, vaccination session, vaccine management etc.
2.	Listing of missed children for routine EPI in campaign tally sheet and in reporting which helps to track missed children and improve coverage
3.	Continue RI session as per annual session plan during campaign and disseminate information during HH visit to vaccinate missed children at nearby RI session
4.	Additional 500 Cold Boxes, 15,000 Vaccine Carriers, 26,000 Ice Packs and 10,000 temperature monitoring devices procured which will further strengthen the cold chain capacity for routine immunization 
5.	Identify High Risk (HR) population groups like population in hard-to-reach (HTR) arears, ethnic groups in Chittagong Hill Track (CHT), worker of Tea garden, Char/Hoar/marshy land, ?Too High To Reach? group in urban, urban slum, working mothers, etc. and implement separate community activation activities with specific communication materials which helping to strengthen RI
6.	375,600 organization units created in DHIS2 for online campaign microplanning of both rural and urban areas which are now used as RI session organization unit for EPI e-tracker implementation to strengthen RI through individual tracking system.
7.	16,000 user ID along with the password created in DHIS2 for union and ward level supervisors which will be used for online supervision for RI session monitoring through mobile apps.
8.	The identified missed area through RCA will be considered as one of the priorities to improve RI</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final report of coverage survey and costing evaluation.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC will provide technical assistance for monitoring and evaluation of oral cholera vaccine introduction, including evaluation of coverage, vaccine delivery costing and potentially impact.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">OCV campaigns continue to face postponement and cancellation due to COVID-19. CDC Foundation intends to return the unspent funds to Gavi.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC will provide technical assistance for monitoring and evaluation of oral cholera vaccine introduction, including evaluation of coverage, vaccine delivery costing and potentially impact.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">OCV campaigns were delayed and some cancelled due to COVID-19. CDC is starting discussions with ICDDR,B to review the timeline for these activities and potentially reprogram the funds. We are considering reprogramming funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. However, the implementation of this tool has also been impacted by the COVID-19 response.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC will provide technical assistance for monitoring and evaluation of oral cholera vaccine introduction, including evaluation of coverage, vaccine delivery costing and potentially impact.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">OCV campaigns were delayed and some cancelled due to COVID-19. CDC is starting discussions with ICDDR,B to review the timeline for these activities and potentially reprogram the funds. We are considering reprogramming funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. However, the implementation of this tool has also been impacted by the COVID-19 response.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Protocol for vaccine coverage survey, costing evaluation and potentially impact.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC will provide technical assistance for monitoring and evaluation of oral cholera vaccine introduction, including evaluation of coverage, vaccine delivery costing and potentially impact.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">OCV campaigns were delayed and some cancelled due to COVID-19. CDC is starting discussions with ICDDR,B to review the timeline for these activities and potentially reprogram the funds. We are considering reprogramming funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. However, the implementation of this tool has also been impacted by the COVID-19 response.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Manuscripts and reports on burden of typhoid, including antimicrobial resistance, in selected sites of Bangladesh. Progress with NITAG recommendations documented.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC will work with our partners in country to provide important data on typhoid data burden to help inform a NITAG recommendation and decision making on a potential TCV application.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">The potential BRAT activity will be delayed until 2022 due to COVID-19. CDC Foundation intends to return the unspent funds to Gavi and use the 2021 SFA funds to support BRAT in Bangladesh.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC will work with our partners in country to provide important data on typhoid data burden to help inform a NITAG recommendation and decision making on a potential TCV application.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">This activity is delayed due to COVID-19. CDC plans to use these funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. The data collated through the tool could be informative for NITAG members when considering TCV introduction. Bangladesh would also be a useful setting to inform tool development, particularly for sub-national vs national interpretations of the data collected through the tool. However, COVID-19 may delay when the BRAT could be done.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC will work with our partners in country to provide important data on typhoid data burden to help inform a NITAG recommendation and decision making on a potential TCV application.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">This activity is delayed due to COVID-19. CDC plans to use these funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. The data collated through the tool could be informative for NITAG members when considering TCV introduction. Bangladesh would also be a useful setting to inform tool development, particularly for sub-national vs national interpretations of the data collected through the tool. However, COVID-19 may delay when the BRAT could be done.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Preparation of materials for NITAG considerations and manuscript drafts of findings regarding disease burden and cost of illness.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC will work with our partners in country to provide important data on typhoid data burden to help inform a NITAG recommendation and decision making on a potential TCV application.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">This activity is delayed due to COVID-19. CDC plans to use these funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. The data collated through the tool could be informative for NITAG members when considering TCV introduction. Bangladesh would also be a useful setting to inform tool development, particularly for sub-national vs national interpretations of the data collected through the tool. However, COVID-19 may delay when the BRAT could be done.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report of initial in-country mission regarding OCV planning and campaign monitoring.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC will provide technical assistance for monitoring and evaluation of oral cholera vaccine introduction, including evaluation of coverage, vaccine delivery costing and potentially impact.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">OCV campaigns were delayed and some cancelled due to COVID-19. CDC is starting discussions with ICDDR,B to review the timeline for these activities and potentially reprogram the funds. We are considering reprogramming funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. However, the implementation of this tool has also been impacted by the COVID-19 response.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report of country level meetings and worksshops for development of the national cholera plan. Development of protocol for piloting the use of OCV in a routine immunization setting. Report of planning meetings with partners for OCV use among the rohingya r</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the Bangladesh Ministry of Health (MOH) and for implemention of the country plan in alignment with the global ending cholera roadmap. Pilot the use of oral cholera vaccine in the routine immunization program in one area in col">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">OCV campaigns were delayed and some cancelled due to COVID-19. CDC is starting discussions with ICDDR,B to review the timeline for these activities and potentially reprogram the funds. We are considering reprogramming funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. However, the implementation of this tool has also been impacted by the COVID-19 response.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical assistance planning meetings with the MOH, key partners (WHO and global taskforce for cholera control, icddrb).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the Bangladesh Ministry of Health (MOH) and for implemention of the country plan in alignment with the global ending cholera roadmap. Pilot the use of oral cholera vaccine in the routine immunization program in one area in col">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">OCV campaigns were delayed and some cancelled due to COVID-19. CDC is starting discussions with ICDDR,B to review the timeline for these activities and potentially reprogram the funds. We are considering reprogramming funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. However, the implementation of this tool has also been impacted by the COVID-19 response.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Development of a draft national cholera control plan. Report on lessons learned from implementation of OCV in a routine immuniztion setting. Report of M &amp; E activities and preliminary results for OCV use among rohingya refugees.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the Bangladesh Ministry of Health (MOH) and for implemention of the country plan in alignment with the global ending cholera roadmap. Pilot the use of oral cholera vaccine in the routine immunization program in one area in collaboration with Icddr,b (identified as a priority operational research agenda topic). Provide technical assistance for planning, monitoring and evaluation of OCV campaigns among the Rohingya refugees.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">OCV campaigns were delayed and some cancelled due to COVID-19. CDC is starting discussions with ICDDR,B to review the timeline for these activities and potentially reprogram the funds. We are considering reprogramming funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. However, the implementation of this tool has also been impacted by the COVID-19 response.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report of an initial in country mission and stakeholder discussions, including sharing of preliminary data on disease burden and cost of illness.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC will work with our partners in country to provide important data on typhoid data burden to help inform a NITAG recommendation and decision making on a potential TCV application.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">This activity is delayed due to COVID-19. CDC plans to use these funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. The data collated through the tool could be informative for NITAG members when considering TCV introduction. Bangladesh would also be a useful setting to inform tool development, particularly for sub-national vs national interpretations of the data collected through the tool. However, COVID-19 may delay when the BRAT could be done.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Planning meetings with MOH, in country partners and global partners regarding TCV application.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support for a&#xA0; potential Gavi application for typhoid conjugate vaccine, including providing critical information on disease burden and antimicrobial resistance in collaboration through existing partnerships in country and globally.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">This activity is delayed due to COVID-19. CDC plans to use these funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. The data collated through the tool could be informative for NITAG members when considering TCV introduction. Bangladesh would also be a useful setting to inform tool development, particularly for sub-national vs national interpretations of the data collected through the tool. However, COVID-19 may delay when the BRAT could be done.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report on progress regarding compilation of burden of disease documentation in preparation for the Gavi application.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support for a&#xA0; potential Gavi application for typhoid conjugate vaccine, including providing critical information on disease burden and antimicrobial resistance in collaboration through existing partnerships in country and globally.">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">This activity is delayed due to COVID-19. CDC plans to use these funds to support implementing the Burden and Risk Assessment of Typhoid (BRAT) tool in Bangladesh. The data collated through the tool could be informative for NITAG members when considering TCV introduction. Bangladesh would also be a useful setting to inform tool development, particularly for sub-national vs national interpretations of the data collected through the tool. However, COVID-19 may delay when the BRAT could be done.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Implemented two communication interventions for tea garden and ethnic communities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for implementation of targeted communication plan for tea garden and ethnic communities">
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF supported EPI, DGHS to develop a robust multi-channel demand generation strategy to ensure consistent, continuous, repetitive communication to reach out ?hard-to-reach? and ?too-high-to-reach? groups. Among the hard-to-reach population, the strategy had employed targeted community engagement strategies for the ?media dark? areas like Chittagong Hill Tracts (CHT) and tea estates in Sylhet division. Considering the context and capacity of the Government and other partners in those areas, a dedicated team is engaged to organize innovative community-based activities in those remote locations. The detail is attached as ?Report on CHT and Tea Garden SBCC activities?.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for implementation of targeted communication plan for tea garden and ethnic communities">
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF supported EPI, DGHS to develop a robust multi-channel demand generation strategy to ensure consistent, continuous, repetitive communication to reach out ?hard-to-reach? and ?too-high-to-reach? groups. Among the hard-to-reach population, the strategy had employed targeted community engagement strategies for the ?media dark? areas like Chittagong Hill Tracts (CHT) and tea estates in Sylhet division. Considering the context and capacity of the Government and other partners in those areas, a dedicated team is engaged to organize innovative community-based activities in those remote locations. The detail is attached as ?Report on CHT and Tea Garden SBCC activities?.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A report summarizing the results of the stakeholder mapping exercise that describes the decision-making pathway and priority information needed for decision-makers (i.e. initial draft of prioritization framework).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="BD"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">Final report now anticipated for January 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report (activities from beginning of grant to Nov 2020.)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="BD"></location>
     </target>
     <actual>
      <location ref="BD"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Convening virtual meetings with key partners to ensure that we are leveraging major existing work and optimizing efficiency within three months of completing initial drafts of the framework.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="test">
      <location ref="BD"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BD"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A prioritization framework available for review, including proposed processes for use of the framework in decision-making, including the outputs from the vaccines included in the framework. OR, if an existing framework is recommended for use, a summary of the process used to modify the existing framework for use by Government of Bangladesh.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="BD"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BD"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data imprvement plan fully implemented and monitored</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Detailed data improvement plan followed by implementation of data improvement plan including strengthening data quality to drive public health intervention through data visualization, eMIS monitoring information system, A2I, RI application that includes immunization trackers, SMS tracking system, reminders, complain and suggestion from public, data triangulation between various sources and other innovative tools">
      <location ref="BD"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">Data improvement plan and data triangulation guideline in coordination with CDC was developed but there is delay in implementation of the plan due to COVID</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">at least 50 % RI imporvemnt activities through MR SIA implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Accelerated Outreach Efforts to measure the impact of SIA activities on catching-up missed vaccination doses">
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">MR campaign was taken as an opportunity to strengthen RI. Report attached</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rota vaccine introduction plan implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for preparation, implementation and evaluation of new vaccine introduction (Rota, HPV and others) and exposure">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">Rota introduction delayed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">at least 5 districts/municiplaities and one CC complete orientation on full immunization innitiative</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement innovative approaches for community mobilization and build ownership for full immunization innitiative &amp; appreciating inquiry,&#xA0;exposure visit and evaluation of full immunization">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">The full immunization initiative guideline has been developed and the orientation plan discussed. It was not possible to conduct the orientation because of the ongoing COVID-19 pandemic. (Please find attached full immunization initiative guideline)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Full immunization decleration in at least few upazilas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement innovative approaches for community mobilization and build ownership for full immunization including verification of full immunization and exposure visit">
      <location ref="BD"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">The full immunization initiative has been implementing in the Noagoan Municipality, Noagoan District for community mobilization and to build ownership. The Municipality has been declared in the EPI model in early 2020. Through this initiative Children under 2-year-old have received appropriate doses of vaccines as per the national EPI schedule and drop-out children have tracked for subsequent doses. Advocacy meeting has been organized with participated of local leaders, City Corporation officials, NGOs, journalist and religion leaders. Orientation/Training of health workers and 1st line supervisors: Orientation/Training has been conducted with an assigned task to them to register all children under 2 years after housing to house visit and ensured vaccination. A computerized EPI database has been developed for all registered children and dropout and left out children were assessed. Dissemination meeting has been conducted with the participation of district administration, local government, National EPI, Journalist, and development partners and declared this Municipality as EPI model. 
 The plan has been developed to implement this innovative initiative in Rajshahi City Corporation. The national team has visited Rajshahi City Corporation in March 2020 and met with the Mayor, Rajshahi City Corporation to share the detailed plan of implementation in that City Corporation. Mayor, Rajshahi City Corporation was excited to implement this initiative in his City Corporation. We are hopeful to start implementing soon after the situation gets improved.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">implementation of activity with evaluation, exposure visit completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Leadership, management and coordination support to EPI and advisory bodies (NITAG, NVC, ICC, NCCPE, LC and others) inclduing exposure visit outside country, develop annual EPI work plan">
      <location ref="BD"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BD"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 50% of activities in the data imporvement plan have been implemented by November 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support implementation of&#xA0; Data Improvement Plan (data triangulation, consilidated DQS data base, digital supportive supervision, establishing data support team and injection logistics management">
      <location ref="BD"></location>
     </target>
     <actual value="On Track">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">Data improvement is ongoing process. Data triangulation guideline was developed in coordination with CDC/US. report attached</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 2 consultative meetings conducted to review JE data and at least 80% of outbreak investigated adequately</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continued technical support for JE and VPD surveillance including investigation of outbreaks as per SoP, identify disadvantaged and leftout population and ensure catch up vaccination">
      <location ref="BD"></location>
     </target>
     <actual value="On Track">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">NITAG meeting were held to review JE burden with possible JE vaccine introduction. Report attached</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continued technical support for JE and VPD surveillance including investigation of outbreaks as per SoP, identify disadvantaged and leftout population and ensure catch up vaccination">
      <location ref="BD"></location>
     </target>
     <actual value="On Track">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">NITAG meeting were held to review JE burden with possible JE vaccine introduction. Report attached</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&gt;80% of cases with adequate samples for lab confirmation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continued technical support for JE and VPD surveillance including investigation of outbreaks as per SoP, identify disadvantaged and leftout population and ensure catch up vaccination">
      <location ref="BD"></location>
     </target>
     <actual value="On Track">
      <location ref="BD"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% of surveillance targets meet</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continued technical support for vaccine safety surveillance, management of adverse event following immunization, risk communication, managemnt of vaccine hesitancy">
      <location ref="BD"></location>
     </target>
     <actual value="On Track">
      <location ref="BD"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continued technical support for vaccine safety surveillance, management of adverse event following immunization, risk communication, managemnt of vaccine hesitancy">
      <location ref="BD"></location>
     </target>
     <actual value="On Track">
      <location ref="BD"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="BD"></location>
     </target>
     <actual value="Completed">
      <location ref="BD"></location>
      <comment>
       <narrative xml:lang="EN">Covid surveillance and stock</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned) 6. LMIS digital package installed 7. Birth notifiation digital package installed 8. Scorecard app installed 9. BNA app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="BD"></location>
     </target>
     <actual>
      <location ref="BD"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned)
6. LMIS digital package installed
7. Birth notifiation digital package installed
8. Scorecard app installed
9. BNA app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="BD"></location>
     </target>
     <actual>
      <location ref="BD"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on planned digital data package or app and know how to use it
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="BD"></location>
     </target>
     <actual>
      <location ref="BD"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="BD"></location>
     </target>
     <actual>
      <location ref="BD"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
